IDL Diagnostics Management
Management criteria checks 1/4
IDL Diagnostics' CEO is Anders Hultman, appointed in Jan 2021, has a tenure of 4.83 years. directly owns 0.49% of the company’s shares, worth SEK492.80K. The average tenure of the management team and the board of directors is 1.8 years and 3.7 years respectively.
Key information
Anders Hultman
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.8yrs |
| CEO ownership | 0.5% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
CEO
Anders Hultman (51 yo)
Mr. Anders Hultman, B.Sc., has been Chief Executive Officer at IDL Diagnostics AB (publ) (formerly known as AroCell AB (publ)) since January 11, 2021. He serves as Director at Polymer Factory Sweden AB sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 4.8yrs | no data | 0.49% SEK 492.8k | |
| Chief Finance Officer | 3.3yrs | no data | no data | |
| Chief Operations Officer | 1.8yrs | no data | no data | |
| Chief Scientific Officer | less than a year | no data | no data | |
| Chief Marketing Officer | 1.8yrs | no data | 0.036% SEK 37.0k | |
| Chief Quality Officer | 1.8yrs | no data | no data |
Experienced Management: IDLDX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 2.8yrs | SEK 150.00k | 0.11% SEK 110.3k | |
| Member of Advisory Board | 4.7yrs | SEK 60.00k | no data | |
| Independent Director | less than a year | no data | no data | |
| Chairman of the Board | 3.8yrs | SEK 208.00k | 0.93% SEK 939.0k | |
| Independent Director | 5.8yrs | SEK 150.00k | 0.052% SEK 52.8k | |
| Independent Director | 3.5yrs | SEK 150.00k | 0.0087% SEK 8.8k |
Experienced Board: IDLDX's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/15 00:34 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IDL Diagnostics AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oscar Bergman | Redeye |